Search research articles
Contact Us
Filters
Showing results (1-10 of 89) with videos related to
Page
of 9
Sort By:
Current Pharmaceutical Biotechnology
|
September 29, 2012
The physiological characteristics and transcytosis mechanisms of the blood-brain barrier (BBB)
Elizabeth C M de Lange
Advanced Drug Delivery Reviews
|
September 24, 2004
Potential role of ABC transporters as a detoxification system at the blood-CSF barrier
Elizabeth C M de Lange
Journal of Pharmacokinetics and Pharmacodynamics
|
February 13, 2013
Utility of CSF in translational neuroscience
Elizabeth C M de Lange
The AAPS Journal
|
October 29, 2021
Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential
Firda Juhairiyah, Elizabeth C M de Lange
Pharmaceutics
|
September 23, 2022
Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model
Makoto Hirasawa, Elizabeth C M de Lange
Clinical Pharmacokinetics
|
August 7, 2002
Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain
Elizabeth C M de Lange, Meindert Danhof
Neuromolecular Medicine
|
June 16, 2014
Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier
Esmée Vendel, Elizabeth C M de Lange
Clinical Pharmacology and Therapeutics
|
February 27, 2022
Understanding the Blood-Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS Therapeutics
Elizabeth C M de Lange, Margareta Hammarlund Udenaes
The AAPS Journal
|
May 30, 2019
Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity
Jean-Marie Nicolas, Elizabeth C M de Lange
The AAPS Journal
|
March 11, 2017
Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations
Yumi Yamamoto, Meindert Danhof, Elizabeth C M de Lange
Page
of 9
Search research articles
Search
Showing results (1-10 of 89) with videos related to
Sort By:
Page
of 9
Current Pharmaceutical Biotechnology
|
September 29, 2012
The physiological characteristics and transcytosis mechanisms of the blood-brain barrier (BBB)
Elizabeth C M de Lange
Advanced Drug Delivery Reviews
|
September 24, 2004
Potential role of ABC transporters as a detoxification system at the blood-CSF barrier
Elizabeth C M de Lange
Journal of Pharmacokinetics and Pharmacodynamics
|
February 13, 2013
Utility of CSF in translational neuroscience
Elizabeth C M de Lange
The AAPS Journal
|
October 29, 2021
Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential
Firda Juhairiyah, Elizabeth C M de Lange
Pharmaceutics
|
September 23, 2022
Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model
Makoto Hirasawa, Elizabeth C M de Lange
Clinical Pharmacokinetics
|
August 7, 2002
Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain
Elizabeth C M de Lange, Meindert Danhof
Neuromolecular Medicine
|
June 16, 2014
Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier
Esmée Vendel, Elizabeth C M de Lange
Clinical Pharmacology and Therapeutics
|
February 27, 2022
Understanding the Blood-Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS Therapeutics
Elizabeth C M de Lange, Margareta Hammarlund Udenaes
The AAPS Journal
|
May 30, 2019
Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity
Jean-Marie Nicolas, Elizabeth C M de Lange
The AAPS Journal
|
March 11, 2017
Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations
Yumi Yamamoto, Meindert Danhof, Elizabeth C M de Lange
Page
of 9